Does TISAGENLECLEUCEL Cause Malignant neoplasm progression? 582 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 582 reports of Malignant neoplasm progression have been filed in association with TISAGENLECLEUCEL (KYMRIAH). This represents 13.8% of all adverse event reports for TISAGENLECLEUCEL.
582
Reports of Malignant neoplasm progression with TISAGENLECLEUCEL
13.8%
of all TISAGENLECLEUCEL reports
400
Deaths
126
Hospitalizations
How Dangerous Is Malignant neoplasm progression From TISAGENLECLEUCEL?
Of the 582 reports, 400 (68.7%) resulted in death, 126 (21.6%) required hospitalization, and 109 (18.7%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TISAGENLECLEUCEL. However, 582 reports have been filed with the FAERS database.
What Other Side Effects Does TISAGENLECLEUCEL Cause?
Cytokine release syndrome (1,660)
Pyrexia (1,030)
Hypotension (425)
Immune effector cell-associated neurotoxicity syndrome (416)
Neurotoxicity (411)
Platelet count decreased (397)
White blood cell count decreased (392)
Hypogammaglobulinaemia (374)
Lymphocyte count decreased (365)
Acute lymphocytic leukaemia recurrent (361)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which TISAGENLECLEUCEL Alternatives Have Lower Malignant neoplasm progression Risk?
TISAGENLECLEUCEL vs TISLELIZUMAB
TISAGENLECLEUCEL vs TISOTUMAB VEDOTIN
TISAGENLECLEUCEL vs TISOTUMAB VEDOTIN-TFTV
TISAGENLECLEUCEL vs TITANIUM DIOXIDE\ZINC
TISAGENLECLEUCEL vs TIVICAY